Impact of Spirometry Race-Correction on Preadolescent Black and White Children.


Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
10 2023
Historique:
received: 28 06 2022
revised: 24 05 2023
accepted: 30 05 2023
pmc-release: 01 10 2024
medline: 9 10 2023
pubmed: 11 6 2023
entrez: 10 6 2023
Statut: ppublish

Résumé

Race-correction for Black patients is standard practice in spirometry testing. History suggests that these corrections are at least partially a result of racist assumptions regarding lung anatomy among Black individuals, which can potentially lead to less frequent diagnoses of pulmonary diseases in this population. To evaluate the impact of race-correction in spirometry testing among Black and White preadolescents, and examine the frequency of current asthma symptoms in Black children who were differentially classified depending on whether race-corrected or race-uncorrected reference equations were deployed. Data from Black and White children who completed a clinical examination at age 10 years from a Detroit-based unselected birth cohort were analyzed. Global Lung Initiative 2012 reference equations were applied to spirometry data using both race-corrected and race-uncorrected (ie, population-average) equations. Abnormal results were defined as values less than the fifth percentile. Asthma symptoms were assessed concurrently using the International Study of Asthma and Allergies in Childhood questionnaire, while asthma control was assessed using the Asthma Control Test. The impact of race-correction on forced expiratory volume in 1 second (FEV Race-correction had an extensive impact on spirometry classification in Black children, and differentially classified children had a higher rate of asthma symptoms than children consistently classified as normal. Spirometry reference equations should be reevaluated to be aligned with current scientific perspectives on the use of race in medicine.

Sections du résumé

BACKGROUND
Race-correction for Black patients is standard practice in spirometry testing. History suggests that these corrections are at least partially a result of racist assumptions regarding lung anatomy among Black individuals, which can potentially lead to less frequent diagnoses of pulmonary diseases in this population.
OBJECTIVE
To evaluate the impact of race-correction in spirometry testing among Black and White preadolescents, and examine the frequency of current asthma symptoms in Black children who were differentially classified depending on whether race-corrected or race-uncorrected reference equations were deployed.
METHODS
Data from Black and White children who completed a clinical examination at age 10 years from a Detroit-based unselected birth cohort were analyzed. Global Lung Initiative 2012 reference equations were applied to spirometry data using both race-corrected and race-uncorrected (ie, population-average) equations. Abnormal results were defined as values less than the fifth percentile. Asthma symptoms were assessed concurrently using the International Study of Asthma and Allergies in Childhood questionnaire, while asthma control was assessed using the Asthma Control Test.
RESULTS
The impact of race-correction on forced expiratory volume in 1 second (FEV
CONCLUSIONS
Race-correction had an extensive impact on spirometry classification in Black children, and differentially classified children had a higher rate of asthma symptoms than children consistently classified as normal. Spirometry reference equations should be reevaluated to be aligned with current scientific perspectives on the use of race in medicine.

Identifiants

pubmed: 37301437
pii: S2213-2198(23)00644-X
doi: 10.1016/j.jaip.2023.05.045
pmc: PMC10592501
mid: NIHMS1909207
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3097-3106

Subventions

Organisme : NIAID NIH HHS
ID : R56 AI050681
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI110450
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL113010
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI089473
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI050681
Pays : United States

Informations de copyright

Copyright © 2023 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Références

Eur Respir J. 2015 Jun;45(6):1582-9
pubmed: 25700383
Arch Dis Child Fetal Neonatal Ed. 2005 Sep;90(5):F423-8
pubmed: 15871993
Eur Respir J. 2010 Dec;36(6):1391-9
pubmed: 20351026
Ann Allergy Asthma Immunol. 2017 Nov;119(5):464-466
pubmed: 28941706
Eur Respir J. 1995 Mar;8(3):483-91
pubmed: 7789502
Cleve Clin J Med. 2003 Oct;70(10):866, 868, 871-3, passim
pubmed: 14621232
J Allergy Clin Immunol. 2021 Nov;148(5):1270-1280
pubmed: 33964299
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Am J Epidemiol. 2004 Nov 1;160(9):893-900
pubmed: 15496542
Semin Reprod Med. 2013 Sep;31(5):333-9
pubmed: 23934693
AJS. 2015 Sep;121(2):396-444
pubmed: 26594713
JAMA Psychiatry. 2022 Feb 1;79(2):93-94
pubmed: 34878501
Ann Fam Med. 2022 Mar-Apr;20(2):157-163
pubmed: 35045967
Curr Opin Endocrinol Diabetes Obes. 2009 Feb;16(1):16-24
pubmed: 19104234
Am J Respir Crit Care Med. 2000 Jan;161(1):309-29
pubmed: 10619836
Nat Genet. 2004 Nov;36(11 Suppl):S54-60
pubmed: 15508005
Ann Allergy Asthma Immunol. 2020 Apr;124(4):342-349
pubmed: 31945477
Int J Obes (Lond). 2020 Oct;44(10):2023-2034
pubmed: 32873910
Eur Respir J. 2005 Nov;26(5):948-68
pubmed: 16264058
J Thorac Cardiovasc Surg. 2014 Jul;148(1):207-11
pubmed: 24060364
J Family Med Prim Care. 2015 Apr-Jun;4(2):187-92
pubmed: 25949965
Respir Care. 2021 Jan;66(1):58-65
pubmed: 32873751
J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138
pubmed: 17983880
J Allergy Clin Immunol. 2006 Mar;117(3):549-56
pubmed: 16522452
BMC Pulm Med. 2018 Jan 19;18(1):10
pubmed: 29351745
BMJ Open. 2019 Jan 9;9(1):e022638
pubmed: 30782683
Curr Epidemiol Rep. 2016 Jun;3(2):161-180
pubmed: 28497013
Am J Epidemiol. 2022 Aug 22;191(9):1521-1526
pubmed: 35792088
Am J Respir Crit Care Med. 1999 Jan;159(1):179-87
pubmed: 9872837
N Engl J Med. 2010 Jul 22;363(4):321-30
pubmed: 20647190
Nat Genet. 2004 Nov;36(11 Suppl):S13-5
pubmed: 15507997
J Allergy Clin Immunol. 2011 Oct;128(4):880-885.e4
pubmed: 21820714
Adv Physiol Educ. 2018 Jun 1;42(2):163-165
pubmed: 29616572
Am J Respir Crit Care Med. 2023 Apr 15;207(8):978-995
pubmed: 36973004
Scoliosis. 2012 Mar 23;7(1):7
pubmed: 22445133
N Engl J Med. 2020 Aug 27;383(9):874-882
pubmed: 32853499
Chest. 2022 Jan;161(1):288-297
pubmed: 34437887
J Hist Med Allied Sci. 2005 Apr;60(2):135-69
pubmed: 15737956
J Youth Adolesc. 1988 Apr;17(2):117-33
pubmed: 24277579
N Engl J Med. 2022 Feb 10;386(6):501-503
pubmed: 35119803
Can J Respir Ther. 2015 Fall;51(4):99-101
pubmed: 26566381
Am J Respir Crit Care Med. 2023 Mar 15;207(6):768-774
pubmed: 36383197
Breathe (Sheff). 2017 Sep;13(3):e56-e64
pubmed: 28955406
Nat Genet. 2004 Nov;36(11 Suppl):S21-7
pubmed: 15507999

Auteurs

Alexandra R Sitarik (AR)

Department of Public Health Sciences, Henry Ford Health, Detroit, Mich. Electronic address: asitari1@hfhs.org.

Ganesa Wegienka (G)

Department of Public Health Sciences, Henry Ford Health, Detroit, Mich.

Christine C Johnson (CC)

Department of Public Health Sciences, Henry Ford Health, Detroit, Mich.

Christine L M Joseph (CLM)

Department of Public Health Sciences, Henry Ford Health, Detroit, Mich.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH